11/12/2024
4:04 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
4:06 PM | JOHNSTON EUGENE M (Reporting)
Mangoceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
7:00 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
4:00 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
7:00 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2024
4:10 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
4:15 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/03/2024
7:30 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
4:25 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
6:30 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:30 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
11:15 PM | Mangoceuticals (Filer)
| Form EFFECT | |
08/30/2024
4:25 PM | Mangoceuticals (Filer)
| Form AW | |
08/27/2024
6:45 PM | Cohen Jacob D. (Filed by)
Mangoceuticals (Subject)
| Form SC 13D/A | |
08/27/2024
6:41 PM | Cohen Jacob D. (Reporting)
Mangoceuticals (Issuer)
Tiger Cub Trust (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
3:41 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
8:25 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
4:15 PM | Mangoceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024
7:00 AM | Mangoceuticals (Filer)
| Form POS AM | |
07/11/2024
7:15 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
3:40 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
5:25 PM | Hamilton Alex P. (Reporting)
Mangoceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
9:20 AM | Hamilton Alex P. (Reporting)
Mangoceuticals (Subject)
| Form 144/A | |
06/20/2024
5:11 PM | Hamilton Alex P. (Reporting)
Mangoceuticals (Subject)
| Form 144/A | |
06/18/2024
1:57 PM | Hamilton Alex P. (Reporting)
Mangoceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
12:28 PM | Hamilton Alex P. (Reporting)
Mangoceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
4:15 PM | D'Alessio Lorraine Pamela (Reporting)
Mangoceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:15 PM | Cohen Jacob D. (Filed by)
Mangoceuticals (Subject)
| Form SC 13D/A | |
06/05/2024
4:15 PM | Cohen Jacob D. (Reporting)
Mangoceuticals (Issuer)
Tiger Cub Trust (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:15 PM | Mangoceuticals (Issuer)
MYERS KENNY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:15 PM | Hamilton Alex P. (Reporting)
Mangoceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:15 PM | Hammer Amanda Elizabeth (Reporting)
Mangoceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:15 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
12:59 PM | Mangoceuticals (Filer)
| Form ARS | |
05/16/2024
8:19 AM | Mangoceuticals (Filer)
| Form DEF 14A | |
05/15/2024
3:52 PM | Mangoceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
8:00 AM | Mangoceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/09/2024
11:15 PM | Mangoceuticals (Filer)
| Form EFFECT | |
05/06/2024
4:32 PM | Mangoceuticals (Filer)
| Form S-1/A | |
05/06/2024
3:43 PM | Mangoceuticals (Filer)
| Form PRE 14A | |
05/02/2024
7:00 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
This Bull Market Indicator called NVDA at $116 (Ad) Every now and again we find an investment idea so incredible we can’t help but share.
And today is one of those rare days…
Except, today we won't be giving you insight on any one particular stock…
But rather, insight on a revolutionary new stock picking indicator…
In fact, within the last year, this indicator has become famous for a multitude of reasons…
But one of the biggest was because of the buy signal it issued on October 18th, 2022.
In fact, on that very day, it said to buy NVDA at $116.37…
Anyone who did would be sitting on a tremendously large return today…
But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here |
04/25/2024
7:30 AM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
4:28 PM | Mangoceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/11/2024
3:30 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
4:21 PM | Mangoceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
4:28 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
8:00 AM | Mangoceuticals (Filer)
| Form DEF 14A | |
02/20/2024
6:32 AM | Mangoceuticals (Filer)
| Form PRE 14A | |
01/25/2024
4:16 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2024
6:42 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
8:51 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
8:51 PM | Cohen Jacob D. (Filed by)
Mangoceuticals (Subject)
| Form SC 13D/A | |
12/29/2023
8:52 PM | Cohen Jacob D. (Reporting)
Mangoceuticals (Issuer)
Tiger Cub Trust (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
11:15 PM | Mangoceuticals (Filer)
| Form EFFECT | |
12/19/2023
3:32 PM | Mangoceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
4:17 PM | Mangoceuticals (Filer)
| Form POS AM | |
12/14/2023
11:15 PM | Mangoceuticals (Filer)
| Form EFFECT | |
12/12/2023
4:14 PM | Mangoceuticals (Filer)
| Form S-1/A | |
12/11/2023
4:29 PM | Mangoceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
